Ceribell Inc
Research Ceribell Inc (CBLL) on Bullrun: market cap USD 903.21M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCBLL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 903.21M
- Financial periodQ2 2026
- RevenueUSD 28.10M
- Net income-USD 19.27M
- Free cash flow-USD 12.18M
- Gross margin92.3%
Valuation Snapshot
latest market cap is USD 903.21M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 89.06M | -USD 53.41M | -USD 41.58M | 87.9% | -1.46 | USD 40.48M | USD 22.28M | USD 155.34M |
| FY2024 | USD 65.44M | -USD 40.46M | -USD 36.38M | 86.7% | -3.39 | USD 194.37M | USD 21.96M | USD 191.17M |
| FY2023 | USD 45.23M | -USD 29.46M | -USD 30.14M | 84.4% | -5.56 | USD 34.50M | USD 14.20M | -USD 112.25M |
| FY2022 | USD 25.92M | -USD 37.16M | -USD 32.52M | 82.9% | -1.59 | USD 68.24M | USD 18.22M | -USD 86.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 903.21M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 822.05M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 927.81M | n/a | n/a | n/a |
About Ceribell Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ceribell Inc's market cap?
Ceribell Inc's market capitalization is USD 903.21M.
What does Ceribell Inc do?
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data.